Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.
about
MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentationFunctional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesisGenome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociGlycosylated VCAM-1 isoforms revealed in 2D western blots of HUVECs treated with tumoral soluble factors of breast cancer cells.Use of lectin microarray to differentiate gastric cancer from gastric ulcer.Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion.O-GlcNAc mediated glycosylation down-regulation in mice with cyclophosphamide induced cystitis.Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.Mumps and ovarian cancer: modern interpretation of an historic association.Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problemGlycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages.Stacking interactions between carbohydrate and protein quantified by combination of theoretical and experimental methods.Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cellsQuantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strainsThe yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSASialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice.Postnatal epigenetic regulation of intestinal stem cells requires DNA methylation and is guided by the microbiomeFizzy: feature subset selection for metagenomicsMUC1-C activates the TAK1 inflammatory pathway in colon cancerPathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Structural glycobiology: a game of snakes and ladders.Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.Eukaryotic protein glycosylation: a primer for histochemists and cell biologistsIdentification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses.Experimental inflammatory bowel disease: insights into the host-microbiota dialog.Golgi pH, its regulation and roles in human disease.Proteoglycan synthesis and Golgi organization in polarized epithelial cells.The role of glycosylation in IBD.Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.Risk of cancer onset in sub-Saharan Africans affected with chronic gastrointestinal parasitic diseases.Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36.Inflammatory cues modulate the expression of secretory product genes, Golgi sulfotransferases and sulfomucin production in LS174T cells.Glycan microarray analysis of Candida glabrata adhesin ligand specificity.The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arraysGut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells.Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice.Glycoprotein Enrichment Analytical Techniques: Advantages and Disadvantages.
P2860
Q24299980-979B16C4-2FF2-45DD-9055-A7EEBA704C7AQ24528157-3D2EDA14-9FD6-4C22-92F2-52F6F8FAC2E5Q24618592-768C0A53-5EE0-4AC6-8889-CBA47336CA57Q30907649-AD87E683-3A00-4F15-B675-8867A6A05A80Q33594943-39B09826-16F1-4224-AC9C-6FFB87D545CEQ33675740-0DE52056-5306-4C5A-ACE2-493EC1C8D19CQ33732445-8DAB40F3-40A2-4599-988D-AF50F1E1EFE7Q33945484-3FB1C94A-2604-496A-8AE3-AB5D40B9801BQ34180646-5A54BECC-20CF-4674-B7F6-7A434F5953FEQ34200023-F7149111-86E0-4705-AB00-75029439BB4FQ34257399-AB84F11E-3BCE-4157-8391-670C0C5E6AB6Q34441077-D295A6A0-6174-498C-AA1F-CD5E2B0EBCE3Q34639786-E42C491F-90A4-4EB5-AF45-1D0DDEA2DAFDQ35159162-A5EFCBB4-462D-481A-89F3-3CE02FFA087AQ35558939-AEE545A8-9614-4E70-927A-8169C6B0F39CQ35565733-825EF4F4-5734-49D8-8BCE-4C86D347B625Q35627540-51AC7462-F820-48C7-A207-2F8C0D856441Q35754002-77B24AD4-474F-49A3-9CD9-F6451802B768Q35792575-97EAA000-4A47-4308-A6A7-D0EF1A253E6EQ35832969-3DE05AEC-3842-4E4D-9347-290F5C6E6BE3Q35931767-EB3BCAA4-6BDA-42AE-A38B-3A6D389890E4Q36328299-B7474E82-5F4D-48CC-A73C-BE3153E8FF9BQ37129248-0F954D51-6383-4DA7-AE20-D5D12E75702DQ37155926-B40B1DFF-F93E-4188-90E2-9B37615061D0Q37639440-54BB55ED-04C8-4E43-A481-B0AD64F52623Q37699416-1051D9D6-FC44-40F3-945F-55F43DC06DFBQ37857437-61ACBCFC-3459-477E-B31D-5E6078E90B87Q37876406-8826CA23-9F78-4AB4-9396-21ECEFC3706AQ38039950-32947D34-CB33-4A59-B3AA-A7207C37E5BCQ38218832-E22FBA29-095A-4F11-B71D-ED46083CA6A9Q38307814-3318090C-60A9-486A-B7CE-0EFD0217E7AFQ38880456-02FB0047-3E60-4AF6-BADC-34CB49EBADA9Q39220487-D97085CA-81DB-4ECD-87E5-9898BBDBAC90Q39439937-CDE1C69D-425C-44F0-BAB0-5C688A64F96AQ39994455-F4EDF025-1697-419A-AF99-F0E2BC933330Q42085701-F92E8ACA-03A7-4848-8781-F066B2EBC49AQ42151699-3DFEBCD0-168B-49F2-A20A-A7D009E931BBQ43186622-BE504FF6-6981-4086-A4FB-7C986E2AB7ADQ45096818-707405FA-BC3D-49B5-82A1-D5D07A9A4833Q49812897-648D5297-FC1E-45C5-B17F-34A57B9A12E2
P2860
Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Altered glycosylation in infla ...... le role in cancer development.
@ast
Altered glycosylation in infla ...... le role in cancer development.
@en
type
label
Altered glycosylation in infla ...... le role in cancer development.
@ast
Altered glycosylation in infla ...... le role in cancer development.
@en
prefLabel
Altered glycosylation in infla ...... le role in cancer development.
@ast
Altered glycosylation in infla ...... le role in cancer development.
@en
P2093
P921
P356
P1476
Altered glycosylation in infla ...... le role in cancer development.
@en
P2093
P2888
P304
P356
10.1023/A:1022240107040
P577
2001-11-01T00:00:00Z
P6179
1006417486